Clinical Study Evaluating Beta Blockers Use and Fracture Risk in Patients With Primary Osteoporosis

Clinical Study Evaluating Selective or Nonselective Beta Blockers Use and Fracture Risk in Patients With Primary Osteoporosis

Clinical study evaluating selective or nonselective beta blockers use and fracture risk in patients with primary osteoporosis

Clinical study evaluating selective or nonselective beta blockers use and if there is fracture risk in patients with primary osteoporosis

Inclusion Criteria:

• • Male & female osteoporotic patient aged ≥ 50 years

  • Hypertensive & normotensive patients
  • BMD T-score ≥ 2.5 or more SD below peak bone mass

Exclusion Criteria:

• Patients on drugs that may improve osteoporosis disease state such as:

  • Angiotensin converting enzyme inhibitor (ACEI) or Angiotensin receptor blockers (ARBs), Thiazide diuretic, Nitrates, Spironolactone, Statins.

Patients on drugs that may worsen osteoporosis disease state such as:

• Corticosteroids, Loop diuretics, Anticonvulsants, Antidepressants, Aromatase inhibitors, Thyroid replacement therapy and Proton pump inhibitors.